Marine Algal Bioactive Compounds for the Management of Non-communicable Chronic Diseases
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 1670
Special Issue Editor
Interests: seaweeds; sulfated polysaccharides; fucoidans; carrageenan; laminarin; fucoxanthin; alginates; ulvans; polyphenols; carotenoids; obesity; type 2 diabetes; cardiovascular; metabolic disorders; hypertension
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Marine algae represent a viable and sustainable source for the extraction of bioactive compounds including polysaccharides, peptides, and polyphenols. These compounds have been reported to possess health benefits and have modulatory effects on many chronic metabolic diseases. The different extraction procedures and the characterization of compounds derived from marine algae have revealed a plethora of ameliorative effects against disease parameters including antioxidant, anti-hyperglycaemic, anticoagulant, anti-inflammatory, anti-viral, anti-cancer, and immunomodulatory effects, making them ideal candidates for the development of novel therapeutics for chronic diseases.
The bioactive compounds derived from marine algae hold a great potential for the development of products with significant therapeutic and biomedical applications. Therefore, this Special Issue aims to highlight the therapeutic potential of compounds derived from marine algae on non- communicable diseases. We invite researchers to contribute original articles, reviews, and perspectives in this regard.
Prof. Dr. Shahidul Islam
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- alginates
- cardiovascular
- carotenoids
- carrageenan
- fucoidans
- fucoxanthin
- hypertension
- laminarin
- metabolic disorders
- obesity
- polyphenols
- seaweeds
- sulfated polysaccharides
- type 2 diabetes
- ulvans
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
